HIMS — Hims & Hers Health, Inc.
—
NYSE ·
Health Care ·
Health Care Providers & Services ·
CIK 1773751 ·
Last close
$17.55
Market Cap
$3.97B
52W High
$40.99
52W Low
$13.74
ADV30
14,068,557
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 890,373,000 | 509,199,000 | -66,146,000 | -33,040,000 | 3,546,862,000 | 605,604,000 | 3,191,565,000 |
| Jun 2026 | 753,214,000 | 480,803,000 | -97,192,000 | -86,290,000 | 3,628,814,000 | 609,811,000 | 3,304,742,000 |
| Mar 2026 | 608,104,000 | 396,787,000 | -78,323,000 | -92,115,000 | 2,267,043,000 | 222,266,000 | 1,820,876,000 |
| Dec 2025 | 617,818,000 | 444,435,000 | 9,186,000 | 20,601,000 | 2,154,705,000 | 228,616,000 | 1,613,777,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$180,122,000
Investing CF
$-70,008,000
Financing CF
$147,430,000
CapEx
$-171,878,000
Dividends Paid
—
Buybacks
$-89,960,000
EPS Diluted TTM
$-0.83
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-325,217,000
Inventory
$107,848,000
Receivables
$427,847,000
ST Investments
$106,617,000
EBIT TTM
$-232,475,000
Pretax Income TTM
$-222,081,000
Interest Exp TTM
—
Analysts
13
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,869,509,120
EBITDA
$-75,537,000
Free Cash Flow
$573,203,392
Enterprise Value
$5,473,491,968
Total Cash
$712,220,992
Total Debt
$1,560,755,968
Shares Out
226,034,799
Trailing EPS
$-0.83
Book Value
$1.52
ROE
-40.8%
ROA
-4.0%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,347,637,000 | 105,613,000 | 128,365,000 | 2,154,705,000 | 1,613,777,000 | 540,928,000 | 300,006,000 |
| Dec 2024 | 1,476,514,000 | 61,903,000 | 126,038,000 | 707,539,000 | 230,823,000 | 476,716,000 | 251,084,000 |
| Dec 2023 | 872,000,000 | -29,453,000 | -23,546,000 | 441,186,000 | 97,157,000 | 344,029,000 | 73,483,000 |
| Dec 2022 | 526,916,000 | -68,697,000 | -65,678,000 | 366,341,000 | 54,600,000 | 311,741,000 | -26,531,000 |
TTM Snapshot
Revenues TTM
$2,578,112,000
NetIncome TTM
$-142,030,000
OpCashFlow TTM
—
Assets (Latest)
$3,628,814,000
Forward EPS
$0.40
Max Pain — expiry 2026-11-27
max pain strike: $20.00 · spot: $17.05 · call oi: 14,528 · put oi: 6,371
Expected Move to 2026-11-27:
±$1.58
(9.27%) —
implied range
$15.47 –
$18.63
· ATM straddle on $17.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CDNA | CareDx, Inc. | $3.92B | $74.56 | — |
| BLLN | BillionToOne, Inc. | $4.22B | $97.50 | — |
| ACHC | Acadia Healthcare Company, Inc. | $3.53B | $37.94 | — |
| SGRY | Surgery Partners, Inc. | $3.51B | $26.85 | — |
| SHC | Sotera Health Co | $4.58B | $16.05 | — |
News headlines (Yahoo Finance, 1h cache)
Could Hims & Hers Stock Fall 63% Again?
2026-11-19 12:41 · Yahoo
Hims Is Getting into Peptides
2026-11-18 17:43 · Yahoo
Hims & Hers Launches Peptides+, a New Clinically-Guided Specialty for Access to Personalized, Proactive Health
2026-11-18 14:00 · Yahoo
Hims & Hers Stock Fell 32% As Profit Slipped
2026-11-17 14:13 · Yahoo
Hims & Hers Health Stock Crashes After Earnings: Is Now the Time to Buy?
2026-11-16 18:56 · Yahoo
Hims & Hers Lost 100K Subscribers Before Adding Eli Lilly’s $299 Zepbound: Buy the Dip, or Wait?
2026-11-16 09:28 · Yahoo
LifeStance, Private Equity Rollup Turned Organic Growth Stock, Targets A Profound Void
2026-11-13 21:19 · Yahoo
Should Hims & Hers Stock's Drop After Earnings Worry You?
2026-11-13 20:23 · Yahoo
Hims & Hers Stock Just Plummeted 17%. Is the Stock a Buy Ahead of a Peptide Push?
2026-11-13 18:00 · Yahoo
HIMS Partners With Lilly to Offer FDA-Approved Weight-Loss Drugs
2026-11-13 15:12 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.